“ARTIFICIAL INTELLIGENCE IS ONE OF THE MOST IMPORTANT TECHNOLOGIES IN THE FIELD OF MEDICINE.”

HeartFlow Technology, Artificial Intelligence, Cardiology…

The Not Old Better Show, 2019.
Image for post
Image for post

Welcome to The Not Old Better Show, Science & Technology Interview Series, I’m Paul Vogelzang and this is episode #375. Today’s episode is brought to you by HeartFlow.

Image for post
Image for post

As part of our Science and Technology Interview series, today’s show is excellent, behind the scenes look into the use of a new heart disease diagnostic test using precise 3D images, and at the same time, it reduces healthcare system costs. Today we’re speaking with HeartFlow co-founder and Chief Technology Officer, Charley Taylor.

Image for post
Image for post
HeartFlow founder and Chief Technology Officer, Charley Taylor, Ph.D.

HeartFlow’s Charley Taylor is that rare combination of businessperson and academician. While getting his Ph.D. in mechanical engineering at Stanford University, Charley Taylor spotted an opportunity to combine computer simulation methods with medical imaging data for patient-specific modeling of blood flow to aid in the diagnosis and treatment of cardiovascular disease.

We’ve talked about Coronary Artery Disease previously, it is the most common type of heart disease…it is the leading cause of death in the US in both men and women, about 735,000 Americans have a heart attack, and over 610,000 people die of heart disease in the United States, according to the Center for Disease Control.

Image for post
Image for post

Charley Taylor answers our questions about Coronary Artery Disease, about potential cost savings to the healthcare system, and future of HeartFlow, and the next healthcare frontier: web, tablets, apps, etc…that emphasize precise visuals, 3D modeling and the sheer power to improve patient care.

We’ll be joined by Charley Taylor in just a moment, but I want to emphasize the importance of how HearfFlow technology transforms the way cardiovascular disease is diagnosed and treated. Further, we’ve been given an excellent brochure from HeartFlow, emphasizing the HeartFlow analysis, to better educate you all about the questions, details, and concerns you may have with respect to Coronary Artery Disease.

Image for post
Image for post
Devices such as smartphones and tablets make expeditious use of time, which can save lives in the treatment of cardiac conditions.

Links to the downloadable brochure will be in today’s show notes (https://hfdc-corpweb.s3-us-west-2.amazonaws.com/assets/docs/HF-3720_PatientBrochure-PGbyPG_Coated-FINAL_2017Jul12/HF-3720_PatientBrochure-PGbyPG_Coated-FINAL_2017Jul12.html), or you can email me at info@notold-better.com, and I’ll make sure you get one, but please if you’re at risk, unsure of your risk, or want to know for a family member, take the next step in a treatment plan that has “demonstrated higher diagnostic performance compared to other non-invasive cardiac tests.” That’s according to published data, the link to which is HERE.

Please, though, now join me in welcoming to The Not Old Better Show via internet phone, Dr. Charley Taylor.

For more information about Charley Taylor, Ph.D., please click here: https://www.heartflow.com/management-team#bio-3

For more information about The Not Old Better Show, please click here: https://notold-better.com

Image for post
Image for post
The Not Old Better Show, Science & Technology Interview Series

Written by

Every week, another story about being better after age 55! Talk About Better. Content, conversation, & community.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store